Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $35.8000 (-2.08%) ($35.7400 - $37.1200) on Tue. May. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.51% (three month average) | RSI | 60 | Latest Price | $35.8000(-2.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 4.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(45%) IWO(42%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -4.255% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-13%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.255% (StdDev 8.51%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
5 Day Moving Average | $35.61(0.53%) | 10 Day Moving Average | $35.41(1.1%) | 20 Day Moving Average | $34.86(2.7%) | To recent high | -7.9% | To recent low | 83.2% | Market Cap | $5.242b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |